SCIMEDX PHASE II MPO IGG ANTIBODY EIA (1281)

Specialty: General Immunology


Welcome to the PulseAid listing for the SCIMEDX PHASE II MPO IGG ANTIBODY EIA medical device. This device is used in the General Immunology healthcare specialty. Below, you can view the analytes this device is used to test, and its corresponding complexity (HIGH, MODERATE, or CLIA WAIVED). We have also randomly listed additional medical devices used in the General Immunology healthcare specialty at the bottom of the page.

Analytes Measured/Detected and Complexity:

ANALYTE	COMPLEXITY
Anti-myeloperoxidase (MPO) antibodies (K010289 | K010289)	HIGH Effective Date: 2001-03-28

Other General Immunology Devices:

Medical Device	Complexity
Phadia 1000	View Complexity
Wieslab AB Wielisa anti-GBM, ANCA Screening Kit	View Complexity
Abbott Aeroset	View Complexity
Ampcor ASO Card Test	View Complexity
Becton Dickinson FACSCalibur	View Complexity
THE BINDING SITE BINDAZYME ENA EIA KIT RANGE	View Complexity
Siemens Dimension Vista System	View Complexity
Crestat Diagnostics N-Assay TIA IgM	View Complexity
BIO-RAD LABORATORIES PLATELIA TOXO IGM ASSAY	View Complexity
Roche Diagnostics Hitachi 912	View Complexity